These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14552587)

  • 41. A common pharmacophore for cytotoxic natural products that stabilize microtubules.
    Ojima I; Chakravarty S; Inoue T; Lin S; He L; Horwitz SB; Kuduk SD; Danishefsky SJ
    Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4256-61. PubMed ID: 10200249
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epothilone and paclitaxel: unexpected differences in promoting the assembly and stabilization of yeast microtubules.
    Bode CJ; Gupta ML; Reiff EA; Suprenant KA; Georg GI; Himes RH
    Biochemistry; 2002 Mar; 41(12):3870-4. PubMed ID: 11900528
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Computational and molecular modeling evaluation of the structural basis for tubulin polymerization inhibition by colchicine site agents.
    ter Haar E; Rosenkranz HS; Hamel E; Day BW
    Bioorg Med Chem; 1996 Oct; 4(10):1659-71. PubMed ID: 8931935
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A unified and quantitative receptor model for the microtubule binding of paclitaxel and epothilone.
    Wang M; Xia X; Kim Y; Hwang D; Jansen JM; Botta M; Liotta DC; Snyder JP
    Org Lett; 1999 Jul; 1(1):43-6. PubMed ID: 10822530
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distances between the paclitaxel, colchicine, and exchangeable GTP binding sites on tubulin.
    Han Y; Malak H; Chaudhary AG; Chordia MD; Kingston DG; Bane S
    Biochemistry; 1998 May; 37(19):6636-44. PubMed ID: 9578547
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structure of tubulin at 6.5 A and location of the taxol-binding site.
    Nogales E; Wolf SG; Khan IA; Ludueña RF; Downing KH
    Nature; 1995 Jun; 375(6530):424-7. PubMed ID: 7760939
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular mobility of nitroxyl-labelled taxol during tubulin assembly.
    Nicholov R; Kingston DG; Chordia MC; DiCosmo F
    FEBS Lett; 1997 Mar; 405(1):73-6. PubMed ID: 9094427
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural comparison of the interaction of tubulin with various ligands affecting microtubule dynamics.
    Stec-Martyna E; Ponassi M; Miele M; Parodi S; Felli L; Rosano C
    Curr Cancer Drug Targets; 2012 Jul; 12(6):658-66. PubMed ID: 22385515
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative binding energy (COMBINE) analysis supports a proposal for the binding mode of epothilones to β-tubulin.
    Coderch C; Klett J; Morreale A; Fernando Díaz J; Gago F
    ChemMedChem; 2012 May; 7(5):836-43. PubMed ID: 22431398
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The relationship between Taxol and (+)-discodermolide: synthetic analogs and modeling studies.
    Martello LA; LaMarche MJ; He L; Beauchamp TJ; Smith AB; Horwitz SB
    Chem Biol; 2001 Sep; 8(9):843-55. PubMed ID: 11564553
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Probing the environment of tubulin-bound paclitaxel using fluorescent paclitaxel analogues.
    Sengupta S; Boge TC; Liu Y; Hepperle M; Georg GI; Himes RH
    Biochemistry; 1997 Apr; 36(17):5179-84. PubMed ID: 9136879
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A rational design of bioactive taxanes with side chains situated elsewhere than on C-13.
    Wu JH; Zamir LO
    Anticancer Drug Des; 2000 Feb; 15(1):73-8. PubMed ID: 10888038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Berberine Induces Toxicity in HeLa Cells through Perturbation of Microtubule Polymerization by Binding to Tubulin at a Unique Site.
    Raghav D; Ashraf SM; Mohan L; Rathinasamy K
    Biochemistry; 2017 May; 56(20):2594-2611. PubMed ID: 28459539
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fluorescent taxoids as probes of the microtubule cytoskeleton.
    Evangelio JA; Abal M; Barasoain I; Souto AA; Lillo MP; Acuña AU; Amat-Guerri F; Andreu JM
    Cell Motil Cytoskeleton; 1998; 39(1):73-90. PubMed ID: 9453715
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 3D electron microscopy of the interaction of kinesin with tubulin.
    Hirose K; Löwe J; Alonso M; Cross RA; Amos LA
    Cell Struct Funct; 1999 Oct; 24(5):277-84. PubMed ID: 15216883
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Investigation of Paclitaxel Resistant R306C Mutation in β-Tubulin—A Computational Approach.
    Verma K; Ramanathan K
    J Cell Biochem; 2015 Jul; 116(7):1318-24. PubMed ID: 25735511
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relating molecular flexibility to function: a case study of tubulin.
    Keskin O; Durell SR; Bahar I; Jernigan RL; Covell DG
    Biophys J; 2002 Aug; 83(2):663-80. PubMed ID: 12124255
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The T-Taxol conformation.
    Alcaraz AA; Mehta AK; Johnson SA; Snyder JP
    J Med Chem; 2006 Apr; 49(8):2478-88. PubMed ID: 16610791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design, synthesis, and bioactivity of putative tubulin ligands with adamantane core.
    Zefirova ON; Nurieva EV; Lemcke H; Ivanov AA; Shishov DV; Weiss DG; Kuznetsov SA; Zefirov NS
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5091-4. PubMed ID: 18715782
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nordihydroguaiaretic acid, of a new family of microtubule-stabilizing agents, shows effects differentiated from paclitaxel.
    Nakamura M; Nakazawa J; Usui T; Osada H; Kono Y; Takatsuki A
    Biosci Biotechnol Biochem; 2003 Jan; 67(1):151-7. PubMed ID: 12619686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.